Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Characterizing rare and low-frequency height-associated variants in the Japanese population.
|
31562340 |
2019 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies.
|
19801982 |
2009 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies.
|
19801982 |
2009 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
New sequence variants associated with bone mineral density.
|
19079262 |
2009 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
|
22504420 |
2012 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
New sequence variants associated with bone mineral density.
|
19079262 |
2009 |
Bone Diseases
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
|
18829486 |
2008 |
Bone Mineral Density Test
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Meta-analysis of gene-based genome-wide association studies of bone mineral density in Chinese and European subjects.
|
21927923 |
2012 |
Bone Mineral Density Test
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture.
|
22504420 |
2012 |
Brachyturricephaly
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Byzanthine arch palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Childhood Osteosarcoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Transfection of the osx gene into the mouse osteosarcoma cells inhibited tumor cell growth in vitro and in vivo and significantly reduced tumor incidence, tumor volume, and lung metastasis following intratibial injection.
|
15734992 |
2005 |
Childhood Osteosarcoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
We used quantitative real-time polymerase chain reaction to evaluate the gene expression of MDM2, CXCR4, RANKL, RB1, and OSTERIX in 98 samples of osteosarcoma taken from 47 patients (74 metastases and 24 primary tumors) and 30 nonmalignant lung tissues surrounding osteosarcoma metastases.
|
23845465 |
2013 |
Childhood Osteosarcoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Osteogenic regulators Runx2 and OSX, and the late marker osteopontin (OPN) expressed at low levels in most OS lines, indicating that most OS cells fail to undergo terminal differentiation.
|
18838962 |
2008 |
Clumsiness - motor delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital pectus carinatum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Craniofacial Abnormalities
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Mutations of the Sp7 gene in humans are associated with craniofacial anomalies and osteogenesis imperfecta.
|
29405385 |
2018 |
Depressed nasal bridge
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Facial asymmetry
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized osteoporosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Giant Cell Tumor of Bone
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
|
15003787 |
2004 |
Late tooth eruption
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Malar flattening
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Micrognathism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|